# Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery

> **NCT00016133** · PHASE1,PHASE2 · COMPLETED · sponsor: **Intracel**

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** BCG vaccine
- **BIOLOGICAL:** autologous tumor cell vaccine
- **DRUG:** fluorouracil
- **DRUG:** leucovorin calcium
- **PROCEDURE:** adjuvant therapy

## Key facts

- **NCT ID:** NCT00016133
- **Lead sponsor:** Intracel
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** — (—)
- **Last updated:** 2013-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00016133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00016133, "Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery". Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/clinical/NCT00016133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*